Escalating to medium‐ versus high‐efficacy disease modifying therapy after low‐efficacy treatment in relapsing remitting multiple sclerosis
Article in Brain and Behavior (April 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients – Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting – Results from the Non-Interventional Study PERFECT
Article in Patient Preference and Adherence (May 2021)
Patterns of local site reactions to subcutaneous glatiramer acetate treatment of multiple sclerosis: a clinicopathological study.
Article in International Journal of Clinical and Experimental Pathology (June 2018)